Latest Glioma Stories

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Micki Klein for the organization she created in honor of her daughter. New York, NY (PRWEB) May 17, 2013 On May 17, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy praises Micki Klein for creating the organization Riah’s Rainbow, in honor of her daughter Mariah who lost her battle with brain cancer. According to a Green Bay Press Gazette...

A novel drug may help increase the effectiveness of radiation therapy for the most deadly form of brain cancer, report scientists at Virginia Commonwealth University Massey Cancer Center. In mouse models of human glioblastoma multiforme (GBM), the new drug helped significantly extend survival when used in combination with radiation therapy. Recently published in the journal Clinical Cancer Research, the study provides the first preclinical evidence demonstrating that an ATM kinase...

Voices Against Brain Cancer commends Baylor University student for appearing on Jeopardy despite suffering from a brain tumor. New York, NY (PRWEB) May 11, 2013 On May 11, Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends Taylor Roth on her recent appearance on Jeopardy, a popular trivia game television show, despite suffering from an inoperable brain tumor. According to Dallas News, Taylor Roth has lived with an inoperable brain tumor...

Voices Against Brain Cancer, an organization dedicated to brain tumor research and advocacy, comments on an article discussing a new finding that may help in diagnosing and treating certain pediatric brain tumor cases. New York, NY (PRWEB) May 03, 2013 On May 3, Voices Against Brain Cancer (VABC), an organization dedicated to brain tumor research and advocacy, comments on an article discussing a new finding that may help doctors in classifying and treating certain pediatric brain tumors....

InCube's San Antonio Innovation Center Expands with Medical Device Companies, Theracle and iBridge Medical SAN ANTONIO and SAN JOSE, Calif., May 2, 2013 /PRNewswire/ -- InCube Labs, a life sciences research lab focused on developing medical breakthroughs that dramatically improve patient outcomes, today announced the launch of two new life sciences companies in San Antonio. Theracle and iBridge Medical join three existing InCube San Antonio companies, Corhythm, Neurolink and Fe3...

A type of low-grade but sometimes lethal brain tumor in children has been found in many cases to contain an unusual mutation that may help to classify, diagnose and guide the treatment of the tumors, report scientists at Dana-Farber Cancer Institute. The researchers led a study of pediatric low-grade gliomas, samples of which were collected through an international consortium organized by brain tumor specialists at Dana-Farber/Children's Hospital Cancer Center. Their findings are being...

"Current wisdom says that cells are closed entities that communicate through the secretion of soluble signalling molecules. Recent findings indicate that cells can exchange more complex information – whole packages of genetic material and signalling proteins. This is an entirely new conception of how cells communicate", says Dr Mattias Belting, Professor of Oncology at Lund University and senior consultant in oncology at Skåne University Hospital, Lund, Sweden. Exosomes are small...

The St. Jude Children's Research Hospital -- Washington University Pediatric Cancer Genome Project advances understanding of genetic defects underlying childhood low-grade gliomas and identifies promising new drug therapies The St. Jude Children's Research Hospital – Washington University Pediatric Cancer Genome Project has identified mutations responsible for more than half of a subtype of childhood brain tumor that takes a high toll on patients. Researchers also found evidence the...

The St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project advances understanding of genetic defects underlying childhood low-grade gliomas and identifies promising new drug therapies MEMPHIS, Tenn., April 14, 2013 /PRNewswire-USNewswire/ -- The St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project has identified mutations responsible for more than half of a subtype of childhood brain tumor that takes a...

VANCOUVER, British Columbia and MENLO PARK, Calif., April 10, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) today announced additional positive interim data from an ongoing Phase I/II clinical trial of VAL-083 in patients with recurrent glioblastoma multiforme (GBM) or progressive secondary brain tumor. The data are being presented at the American Association for Cancer Research (AACR) Annual Meeting in Washington, D.C. during a clinical poster session entitled,...